196 related articles for article (PubMed ID: 16157591)
1. Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis.
Kristiansen M; Messenger MJ; Klöhn PC; Brandner S; Wadsworth JD; Collinge J; Tabrizi SJ
J Biol Chem; 2005 Nov; 280(46):38851-61. PubMed ID: 16157591
[TBL] [Abstract][Full Text] [Related]
2. Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation.
Yadavalli R; Guttmann RP; Seward T; Centers AP; Williamson RA; Telling GC
J Biol Chem; 2004 May; 279(21):21948-56. PubMed ID: 15026410
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of p62/SQSTM1 in prion diseases and its association with pathogenic prion protein.
Homma T; Ishibashi D; Nakagaki T; Satoh K; Sano K; Atarashi R; Nishida N
Sci Rep; 2014 Mar; 4():4504. PubMed ID: 24675871
[TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibitors promote the sequestration of PrPSc into aggresomes within the cytosol of prion-infected CAD neuronal cells.
Dron M; Dandoy-Dron F; Farooq Salamat MK; Laude H
J Gen Virol; 2009 Aug; 90(Pt 8):2050-2060. PubMed ID: 19339478
[TBL] [Abstract][Full Text] [Related]
5. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity.
Hetz C; Russelakis-Carneiro M; Wälchli S; Carboni S; Vial-Knecht E; Maundrell K; Castilla J; Soto C
J Neurosci; 2005 Mar; 25(11):2793-802. PubMed ID: 15772339
[TBL] [Abstract][Full Text] [Related]
6. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol.
Ma J; Lindquist S
Science; 2002 Nov; 298(5599):1785-8. PubMed ID: 12386336
[TBL] [Abstract][Full Text] [Related]
7. Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration.
Lin Z; Zhao D; Yang L
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):477-84. PubMed ID: 23449072
[TBL] [Abstract][Full Text] [Related]
8. Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin-proteasome system.
McKinnon C; Goold R; Andre R; Devoy A; Ortega Z; Moonga J; Linehan JM; Brandner S; Lucas JJ; Collinge J; Tabrizi SJ
Acta Neuropathol; 2016 Mar; 131(3):411-25. PubMed ID: 26646779
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein 70 selectively mediates the degradation of cytosolic PrPs and restores the cytosolic PrP-induced cytotoxicity via a molecular interaction.
Zhang J; Wang K; Guo Y; Shi Q; Tian C; Chen C; Gao C; Zhang BY; Dong XP
Virol J; 2012 Dec; 9():303. PubMed ID: 23216755
[TBL] [Abstract][Full Text] [Related]
10. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity.
Bate C; Salmona M; Diomede L; Williams A
J Biol Chem; 2004 Apr; 279(15):14983-90. PubMed ID: 14754889
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol.
Ma J; Wollmann R; Lindquist S
Science; 2002 Nov; 298(5599):1781-5. PubMed ID: 12386337
[TBL] [Abstract][Full Text] [Related]
12. Flow Cytometric Detection of PrP
Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046463
[TBL] [Abstract][Full Text] [Related]
13. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
[TBL] [Abstract][Full Text] [Related]
14. Combined pharmacological, mutational and cell biology approaches indicate that p53-dependent caspase 3 activation triggered by cellular prion is dependent on its endocytosis.
Sunyach C; Checler F
J Neurochem; 2005 Mar; 92(6):1399-407. PubMed ID: 15748158
[TBL] [Abstract][Full Text] [Related]
15. Molecular morphology and toxicity of cytoplasmic prion protein aggregates in neuronal and non-neuronal cells.
Grenier C; Bissonnette C; Volkov L; Roucou X
J Neurochem; 2006 Jun; 97(5):1456-66. PubMed ID: 16696854
[TBL] [Abstract][Full Text] [Related]
16. Acute exposure to prion infection induces transient oxidative stress progressing to be cumulatively deleterious with chronic propagation in vitro.
Haigh CL; McGlade AR; Lewis V; Masters CL; Lawson VA; Collins SJ
Free Radic Biol Med; 2011 Aug; 51(3):594-608. PubMed ID: 21466851
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of P53-related apoptosis had no effect on PrP(Sc) accumulation and prion disease incubation time.
Engelstein R; Grigoriadis N; Greig NH; Ovadia H; Gabizon R
Neurobiol Dis; 2005 Mar; 18(2):282-5. PubMed ID: 15686956
[TBL] [Abstract][Full Text] [Related]
18. Optical imaging detects apoptosis in the brain and peripheral organs of prion-infected mice.
Drew SC; Haigh CL; Klemm HM; Masters CL; Collins SJ; Barnham KJ; Lawson VA
J Neuropathol Exp Neurol; 2011 Feb; 70(2):143-50. PubMed ID: 21343883
[TBL] [Abstract][Full Text] [Related]
19. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods.
Shaked GM; Meiner Z; Avraham I; Taraboulos A; Gabizon R
J Biol Chem; 2001 Apr; 276(17):14324-8. PubMed ID: 11152454
[TBL] [Abstract][Full Text] [Related]
20. The cellular prion protein (PrPC) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation.
Kim BH; Lee HG; Choi JK; Kim JI; Choi EK; Carp RI; Kim YS
Brain Res Mol Brain Res; 2004 Apr; 124(1):40-50. PubMed ID: 15093684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
